Eli Lilly and Co (LLY)

Add to Watchlists
Create an Alert
Quickflows
120.64 +0.40  +0.33% NYSE Dec 10, 16:19 Delayed 2m USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All LLY News

News

View All Events

Events

Date Type Description
10/27/2020 09:00 EDT Misc Eli Lilly and Co Third Quarter Earnings Conference Call for 2020
10/27/2020 Earnings Eli Lilly and Co Third Quarter Earnings in 2020 Release
07/30/2020 09:00 EDT Misc Eli Lilly and Co Second Quarter Earnings Conference Call for 2020
07/30/2020 Earnings Eli Lilly and Co Second Quarter Earnings in 2020 Release
04/23/2020 09:00 EDT Misc Eli Lilly and Co First Quarter Earnings Conference Call for 2020
04/23/2020 Earnings Eli Lilly and Co First Quarter Earnings in 2020 Release
01/30/2020 09:00 EST Misc Eli Lilly and Co Fourth Quarter Earnings Conference Call for 2019
01/30/2020 Earnings Eli Lilly and Co Fourth Quarter Earnings in 2019 Release
11/14/2019 Dividends Amount: 0.645, Declared Date: Oct 21 2019, Pay Date: Dec 10 2019
10/23/2019 09:00 EDT Misc Eli Lilly and Co Third Quarter Earnings Conference Call in 2019
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 24.91B
Total Expenses (TTM) 18.62B
Net Income (TTM) 7.948B

Balance Sheet View Statement

Total Assets (Quarterly) 37.89B
Total Liabilities (Quarterly) 34.43B
Shareholders Equity (Quarterly) 3.382B

Cash Flow Statement View Statement

Cash from Operations (TTM) 4.322B
Cash from Investing (TTM) -8.700B
Cash from Financing (TTM) -2.851B

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.lilly.com
  • Investor Relations URL: https://investor.lilly.com/
  • HQ State/Province: Indiana
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Jan. 30, 2020
  • Last Earnings Release: Oct. 23, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Nov. 14, 2019
  • Description: Eli Lilly is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Forteo for osteoporosis; Jardiance, Trulicity, Humalog, and Humulin for diabetes; Taltz and Olumiant for immunology; and Cialis for erectile dysfunction.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 120.64
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
VGHCX Vanguard Health Care Inv 4.27%
VPMCX Vanguard PRIMECAP Inv 4.00%
VHCOX Vanguard Capital Opportunity Inv 3.65%
VPCCX Vanguard PRIMECAP Core Inv 3.24%
XLV Health Care Select Sector SPDR® ETF 2.74%
POGRX PRIMECAP Odyssey Growth 2.69%
IYH iShares US Healthcare ETF 2.52%
VHT Vanguard Health Care ETF 2.40%
FHLC Fidelity® MSCI Health Care ETF 2.38%
FTCS First Trust Capital Strength ETF 2.12%
QUAL iShares Edge MSCI USA Quality Factor ETF 1.63%
VEIPX Vanguard Equity-Income Inv 1.30%

Comparables

Edit
AMGN Amgen Inc
BIIB Biogen Inc
GILD Gilead Sciences Inc
JNJ Johnson & Johnson
MRK Merck & Co Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.